A Madison venture capital firm focused on the work of next-generation researchers and entrepreneurs has completed fund-raising for its newest early-stage investment fund. Venture Investors, LLC now has a total of $115 million to continue its support of companies that are spinning out of the...
Cambridge Major Laboratories has hired James Davidson as its chief operating officer. He has 23 year's experience in the pharmaceutical industry, most recently as a vice president with Pfizer....
Everybody wants to hype the latest “discovery” made possible by stem-cell research, but columnist Tom Still states that these revelations must be accompanied by perspective. In this edition of Inside Wisconsin, he notes that stem-cell research offers hope that science will learn more until diagnostics,...
Thomas Albert, director of advanced research for NimbleGen, will be the lead investigator on a two-year, $415,000 grant award to develop new technology for DNA sequence analysis. ...
After a rather lackluster first quarter, the overall stock market surged back in Q2, and life science stocks continued their torrid pace, according to columnist Michael Rosen. In this edition of Yer Biotech Blues, he chronicles who's hot, who's not so hot, and the prospects...
NanoRite, part business incubator and part innovation center, has opened on the Chippewa Valley Technical College to promote the nanotech research and industry in northwestern Wisconsin. The center, built with funding from the state and federal governments and private donors, will foster collaboration between CVTC,...
The State Senate Democratic Caucus made a bold healthcare proposal last week, but in the process declined to provide additional funding for Act 255, the tax credit program that is credited with boosting investment in early-stage Wisconsin companies....
All signs point to Aruna Biomedical, an Athens, Georgia-based maker of neural stem cell kits for researchers, remaining in Georgia despite efforts to lure it to Wisconsin. Dick Leazer, a principal in Wisconsin Investment Partners, believes the company has found the equity investment it needs...
When it comes to approving drugs in the United States, should safety be the primary endpoint for approval? In this second part of a MedTech Futures column on the FDA approval process, Dr. Ogan Gurel calls for the FDA to refocus its primary mission on...
Madison Area Technical College will host a technology experience for girls June 26-28. Forty-five girls in grades six through nine are expected to attend the event, which is sponsored by area technology companies. ...